Zika virus is affecting people staying in Zika-infested regions and also the infection is linked with many babies being born with underdeveloped brains. This is attributed to the high risk of infection. Zika virus vaccines are gaining popularity, and FDA has passed priority review voucher system for it.
Zika Virus Vaccines Market Report, published by Allied Market Research, forecasts that the global market is expected to garner $18,697 million by 2022, registering a CAGR of 5.2% during the forecast period 2017-2022.Key opportunities include the need for vaccines for immunization & prevention of further spread of Zika virus infection and for treatment of Zika-linked birth defects.
Zika virus infection is a mosquito-borne illness transmitted through Aedes genus same as other mosquito-borne illness such as japanese encephalitis virus, West Nile viruses, and yellow fever virus. It is also transmitted through sexual contact with an infected person or through an infected pregnant woman to the fetus. The report includes the potential market for Zika vaccines market size and covers the total priority target population that resides in Zika-infested region such as female population in reproductive age, travelers in Zika-infested zones, and the total population residing in Zika-infested zones.
Get the PDF brochure of this market: https://www.alliedmarketresearch.com/request-sample/1817
The global potential analysis of Zika Virus vaccines market forecast is analyzed based on forecast scenario such as rapid growth scenario, moderate growth scenario, and low growth scenario. In the rapid growth scenario, maximum percentage of total population in Zika-infested zones is estimated to be vaccinated in the first year launch of Zika virus vaccine in the market.
The outbreak of Zika virus infection in Latin American Countries, especially in Brazil, in last two years; its continuous spread in North America, Asia-Pacific, and Middle East & Africa; and lack of effective medicinal solutions for the prevention & treatment are major challenges faced by the healthcare and government agencies.
Do Purchase Inquiry@ https://www.alliedmarketresearch.com/purchase-enquiry/1817
Multiple key players in the global pharmaceutical & vaccine manufacturing industry focus on the development of Zika virus vaccine and collaborate with the government organizations for the same. Key players engaged in the development of the vaccine include Immunovaccine Inc., Takeda Pharmaceutical Co. Ltd., Bharat Biotech International Ltd., NewLink Genetics Co., Inovio Pharmaceuticals, Inc., GeneOne Life Science Inc., GlaxoSmithKline plc., Sanofi S.A., and Hawaii Biotech Inc.